Drug Type Small molecule drug |
Synonyms EC17, Folate FITC, UB-TT170 |
Target |
Mechanism FOLR1 modulators(Folate receptor alpha modulators), Diagnostic dye |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Start Date20 May 2022 |
Sponsor / Collaborator |
Start Date01 May 2014 |
Sponsor / Collaborator |
Start Date01 Nov 2013 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Renal Cell Carcinoma | Phase 2 | US | 01 Jun 2007 | |
Neoplasm Metastasis | Phase 1 | US | 01 Sep 2005 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 2 | 27 | ybvqsmaufw(exhvbwgekx) = yjxnhgphza sljxabqfje (dniviwkbjn, pjfvwcfxtc - xtibdrmdui) View more | - | 14 Oct 2020 | |||
Phase 1 | 11 | EC90 vaccine | jnchtfhjwu(ubrmvwfomk) = wveugzqrbm rbgpelyhyu (yzuxekjesb ) | - | 20 May 2008 | ||
jnchtfhjwu(ubrmvwfomk) = siozbmtone rbgpelyhyu (yzuxekjesb ) |